Cite
HARVARD Citation
Zhang, H. et al. (2022). A combination of humanized anti-BCMA and murine anti-CD38 CAR-T cell therapy in patients with relapsed or refractory multiple myeloma. Leukemia & lymphoma. 63 (6), pp. 1418-1427. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, H. et al. (2022). A combination of humanized anti-BCMA and murine anti-CD38 CAR-T cell therapy in patients with relapsed or refractory multiple myeloma. Leukemia & lymphoma. 63 (6), pp. 1418-1427. [Online].